Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Environmental Contamination Due to Methicillin-Resistant Staphylococcus aureus: Possible Infection Control Implications
1997
Infective Endocarditis
2005 Standout
In Vitro Activity of Doripenem in Combination with Various Antimicrobials Against Multidrug-Resistant Acinetobacter baumannii : Possible Options for the Treatment of Complicated Infection
2013
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy
2006
Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies
2009
Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study
2007
Vulvovaginal candidosis
2007 Standout
Posaconazole for the Treatment of Azole-Refractory Oropharyngeal and Esophageal Candidiasis in Subjects with HIV Infection
2007
Molecular mechanisms of antibiotic resistance
2014 Standout
Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections
2013
Infection Control and Cost Control in the Era of Managed Care
2002
The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
2007 Standout
Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics
2011
Pneumonia Caused by Methicillin‐ResistantStaphylococcus aureus
2008
Incidence and Outcomes Associated With Infections Caused by Vancomycin-Resistant Enterococci in the United States: Systematic Literature Review and Meta-Analysis
2016
In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates
2007
Changes in the Prevalence of Vancomycin‐Resistant Enterococci in Response to Antimicrobial Formulary Interventions: Impact of Progressive Restrictions on Use of Vancomycin and Third‐Generation Cephalosporins
2003
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
2007 Standout
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Infection Control — A Problem for Patient Safety
2003 Standout
Synergy testing of multidrug resistant Acinetobacter baumanii against tigecycline and polymyxin using an E-test methodology
2007
Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: A propensity-matched analysis*
2010
Blood culture-guided de-escalation of empirical antimicrobial regimen for critical patients in an online antimicrobial stewardship programme
2014
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
What is in the pipeline for Gram-negative pathogens?
2008
A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study
2010
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Management of meningitis due to antibiotic-resistant Acinetobacter species
2009
Challenging Recommended Oral and Intravenous Voriconazole Doses for Improved Efficacy and Safety: Population Pharmacokinetics–Based Analysis of Adult Patients With Invasive Fungal Infections
2012
Penicillin skin testing in patients with a history of β-lactam allergy
2007
Emergence and management of drug-resistant enterococcal infections
2008
Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America
2006 Standout
Clinical Outcomes for Patients with Bacteremia Caused by Vancomycin‐Resistant Enterococcus in a Level 1 Trauma Center
2002
Meta-analysis of Randomized Controlled Trials of Vancomycin for the Treatment of Patients With Gram-Positive Infections: Focus on the Study Design
2012
Prolonged Colonization with Vancomycin‐ResistantEnterococcus faeciumin Long‐Term Care Patients and the Significance of “Clearance”
2001
Vancomycin-resistant enterococci: consequences for therapy and infection control
2005
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
Impact of Ring Wearing on Hand Contamination and Comparison of Hand Hygiene Agents in a Hospital
2003
Sepsis and septic shock
2018 Standout
Posaconazole: a broad-spectrum triazole antifungal
2005
Characterization ofPseudomonas aeruginosaIsolates: Occurrence Rates, Antimicrobial Susceptibility Patterns, and Molecular Typing in the Global SENTRY Antimicrobial Surveillance Program, 1997–1999
2001
Reasons for Noncompliance With Infection Control Guidelines
2000
Management of Urinary Tract Infections From Multidrug-Resistant Organisms
2013
Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management
2015
Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations
2006
Clinical Outbreak of Linezolid-Resistant <emph type="ital">Staphylococcus aureus</emph> in an Intensive Care Unit
2010
Predicting Hospital Rates of Fluoroquinolone-Resistant Pseudomonas aeruginosa from Fluoroquinolone Use in US Hospitals and Their Surrounding Communities
2004
A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia☆
2000
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Antibiotic resistance in the absence of antimicrobial use: mechanisms and implications
2008
British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections
2003
Predictors of Mortality for Methicillin-Resistant Staphylococcus aureus Health-Care–Associated Pneumonia
2006
Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: A systematic review and meta-analysis*
2010
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
Loading dose of vancomycin in critically ill patients: 15mg/kg is a better choice than 500mg
2006
Vancomycin-resistant enterococci: 15 years and counting
2003
Antimicrobial resistance among gram-negative organisms in the intensive care unit
2003
Outcomes Associated With Vancomycin-Resistant Enterococci: A Meta-Analysis
2003
Plasma Fluoride Level as a Predictor of Voriconazole-Induced Periostitis in Patients With Skeletal Pain
2014
Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting
2015 Standout
Health and Economic Outcomes of Vancomycin-Resistant Enterococci
2002
Correlation between veterinary antimicrobial use and antimicrobial resistance in food-producing animals: a report on seven countries
2013
Clinical history as a predictor of penicillin skin test outcome
2006
Ventilator-associated Pneumonia
2002 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Health Care–Associated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections
2002 Standout
Global trends in antimicrobial use in food animals
2015 Standout
The effects of on-screen, point of care computer reminders on processes and outcomes of care
2009
Reference Group Choice and Antibiotic Resistance Outcomes
2004
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Determinants of Vancomycin Resistance and Mortality Rates in Enterococcal Bacteremia: A Prospective Multicenter Study
2001
Current and Emerging Azole Antifungal Agents
1999 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Response to Emerging Infection Leading to Outbreak of Linezolid-Resistant Enterococci
2007
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
2008
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Three Decades of β-Lactamase Inhibitors
2010 Standout
Reengineering Antibiotics to Combat Bacterial Resistance: Click Chemistry [1,2,3]‐Triazole Vancomycin Dimers with Potent Activity against MRSA and VRE
2016 StandoutNobel
New Technology for Detecting Multidrug-Resistant Pathogens in the Clinical Microbiology Laboratory
2001
Total Syntheses and Initial Evaluation of [Ψ[C(═S)NH]Tpg4]vancomycin, [Ψ[C(═NH)NH]Tpg4]vancomycin, [Ψ[CH2NH]Tpg4]vancomycin, and Their (4-Chlorobiphenyl)methyl Derivatives: Synergistic Binding Pocket and Peripheral Modifications for the Glycopeptide Antibiotics
2015
Burn Wound Infections
2006 Standout
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Prosthetic Joint Infection
2014 Standout
Synthetic Riboswitches That Induce Gene Expression in Diverse Bacterial Species
2010 StandoutNobel
Origins and Evolution of Antibiotic Resistance
2010 Standout
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Guidelines for Treatment of Candidiasis
2004 Standout
The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs
2005 Standout
Microbiota regulates immune defense against respiratory tract influenza A virus infection
2011 Standout
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies
2008
Comparison of Mortality Associated with Vancomycin-Resistant and Vancomycin-Susceptible Enterococcal Bloodstream Infections: A Meta-analysis
2005
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
2012
Global Challenge of Multidrug-ResistantAcinetobacter baumannii
2007 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship
2006 Standout
Works of Michael Postelnick being referenced
Evaluation of Hepatotoxicity with Off-Label Oral-Treatment Doses of Voriconazole for Invasive Fungal Infections
2010
Impact of Inactive Empiric Antimicrobial Therapy on Inpatient Mortality and Length of Stay
2006
Potential Impact of Vancomycin Pulmonary Distribution on Treatment Outcomes in Patients with Methicillin‐Resistant Staphylococcus aureus Pneumonia
2006
The utility of aminoglycosides in an era of emerging drug resistance
1998
Management of fluoroquinolone resistance in Pseudomonas aeruginosa—Outcome of monitored use in a referral hospital
1998
The Incidence of Antimicrobial Allergies in Hospitalized Patients
2000
Differences in Clinical Outcomes in Patients with Vancomycin‐Resistant Enterococci According to Linezolid Susceptibility
2010
Enterococcus faecium Bacteremia
1998
Use of Physician Education and Computer Alert to Improve Targeted Use of Gastroprotection Among NSAID Users
2008
Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis
2009
Survey of Vancomycin Monitoring Guidelines in Illinois Hospitals
1988
Molecular typing for investigating an outbreak of Candida krusei
1996
In Vitro Activities of Various Antimicrobials Alone and in Combination with Tigecycline against Carbapenem-Intermediate or -Resistant Acinetobacter baumannii
2007
Breakthrough Candida Infections in Patients Receiving Voriconazole
2005
Peritoneal Fluid Penetration of Tigecycline
2006
Drug Interactions Involving Antifungal Drugs: Time Course and Clinical Significance
2010
Increasing Incidence of Linezolid-Intermediate or -Resistant, Vancomycin-Resistant Enterococcus faecium Strains Parallels Increasing Linezolid Consumption
2008